Aliases & Classifications for Autoimmune Disease

MalaCards integrated aliases for Autoimmune Disease:

Name: Autoimmune Disease 58 12 30 17
Autoimmune Diseases 56 44 74
Autoimmune Hypersensitivity Disease 12 15
Hypersensitivity Reaction Type Ii Disease 12
Type Ii Hypersensitivity Reaction Disease 17
Autoimmune Disorder 15

Characteristics:

OMIM:

58
Inheritance:
autosomal dominant gene epistatic to other secondary genes conferring specificity to the autoimmune phenotype


HPO:

33
autoimmune disease:
Inheritance autosomal dominant inheritance


Classifications:



External Ids:

Disease Ontology 12 DOID:417
OMIM 58 109100
ICD9CM 36 720
MedGen 43 C0004364
SNOMED-CT via HPO 70 263681008

Summaries for Autoimmune Disease

MedlinePlus : 44 Your body's immune system protects you from disease and infection. But if you have an autoimmune disease, your immune system attacks healthy cells in your body by mistake. Autoimmune diseases can affect many parts of the body. No one is sure what causes autoimmune diseases. They do tend to run in families. Women - particularly African-American, Hispanic-American, and Native-American women - have a higher risk for some autoimmune diseases. There are more than 80 types of autoimmune diseases, and some have similar symptoms. This makes it hard for your health care provider to know if you really have one of these diseases, and if so, which one. Getting a diagnosis can be frustrating and stressful. Often, the first symptoms are fatigue, muscle aches and a low fever. The classic sign of an autoimmune disease is inflammation, which can cause redness, heat, pain and swelling. The diseases may also have flare-ups, when they get worse, and remissions, when symptoms get better or disappear. Treatment depends on the disease, but in most cases one important goal is to reduce inflammation. Sometimes doctors prescribe corticosteroids or other drugs that reduce your immune response.

MalaCards based summary : Autoimmune Disease, also known as autoimmune diseases, is related to vitiligo-associated multiple autoimmune disease susceptibility 1 and autoimmune disease of endocrine system. An important gene associated with Autoimmune Disease is GAS5 (Growth Arrest Specific 5), and among its related pathways/superpathways are Allograft rejection and Th17 cell differentiation. The drugs Sofosbuvir and Ledipasvir have been mentioned in the context of this disorder. Affiliated tissues include t cells, testes and bone, and related phenotypes are autoimmune antibody positivity and hematopoietic system

Disease Ontology : 12 An immune system disease that is an overactive immune response of the body against substances and tissues normally present in the body resulting from an abnormal functioning of the immune system that results in the production of antibodies or T cell directed against the host tissues.

Wikipedia : 77 An autoimmune disease is a condition arising from an abnormal immune response to a normal body part.... more...

Description from OMIM: 109100

Related Diseases for Autoimmune Disease

Diseases related to Autoimmune Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 812, show less)
# Related Disease Score Top Affiliating Genes
1 vitiligo-associated multiple autoimmune disease susceptibility 1 34.8 AIRE CTLA4 NLRP1 PTPN22
2 autoimmune disease of endocrine system 34.1 AIRE CTLA4 IFNG PTPN22
3 autoimmune disease of eyes, ear, nose and throat 34.0 IL10 IL17A TNF
4 autoimmune disease of musculoskeletal system 34.0 APOH IL10 IL17A PTPN22 TNF TNFSF13B
5 autoimmune disease of central nervous system 34.0 IFNG IL10 IL17A MBP TNF
6 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 33.6 AIRE CTLA4 IFNG IL10 IL17A PTPN22
7 hashimoto thyroiditis 33.1 AIRE CTLA4 IFNG PTPN22
8 lupus erythematosus 33.1 APOH CTLA4 IL10 NLRP1 PTPN22 TNF
9 rheumatoid arthritis 32.9 CTLA4 IFNG IL10 IL17A NLRP1 PTPN22
10 neuromyelitis optica 32.9 IL17A MBP TNFSF13B
11 multiple sclerosis 32.9 CTLA4 IFNG IL10 IL17A MBP TNF
12 systemic lupus erythematosus 32.9 APOH CTLA4 IFNG IL10 IL17A NLRP1
13 mixed connective tissue disease 32.9 APOH IFNG IL10 TNF
14 alopecia areata 32.8 AIRE CTLA4 IFNG PTPN22 TNF
15 myasthenia gravis 32.7 AIRE CTLA4 IFNG IL10 MBP TNF
16 autoimmune pancreatitis 32.7 CTLA4 ENO1 IL10 TNFSF13B
17 diabetes mellitus, insulin-dependent 32.6 AIRE CTLA4 IFNG IL10 PTPN22
18 autoimmune uveitis 32.6 IFNG IL10 IL17A TNF
19 vogt-koyanagi-harada disease 32.6 IL10 IL17A NLRP1 PTPN22
20 behcet syndrome 32.5 APOH CTLA4 ENO1 IFNG IL10 IL17A
21 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 32.5 AIRE IFNG IL10
22 autoimmune myocarditis 32.5 IFNG TNF
23 autoimmune addison disease 32.2 AIRE CTLA4 NLRP1
24 punctate inner choroidopathy 32.1 IL10 TNF
25 reactive arthritis 32.1 IFNG IL10 IL17A TNF
26 melioidosis 32.1 IFNG IL10 TNF
27 autoimmune retinopathy 32.1 AIRE ENO1
28 interstitial lung disease 32.1 IFNG IL10 TNF
29 autoimmune optic neuritis 32.1 IL10 IL17A MBP
30 autoimmune atherosclerosis 32.0 APOH IL10
31 immune system disease 32.0 APOH IFNG IL10 IL17A MBP TNF
32 arthritis 31.8 IFNG IL10 IL17A NLRP1 PTPN22 TNF
33 hematopoietic stem cell transplantation 31.7 CTLA4 IFNG IL10 TNF
34 vasculitis 31.4 APOH TNF TNFSF13B
35 uveitis 31.1 CTLA4 IFNG IL10 IL17A TNF
36 colitis 31.1 CTLA4 IFNG IL10 IL17A TNF
37 connective tissue disease 31.0 APOH IFNG IL10 TNF TNFSF13B
38 ulcerative colitis 30.9 IFNG IL10 IL17A TNF
39 common variable immunodeficiency 30.9 CTLA4 IFNG IL10 TNF TNFSF13B
40 dermatitis, atopic 30.8 IFNG IL10 IL17A TNF
41 graft-versus-host disease 30.8 IFNG IL10 TNF
42 neuritis 30.8 IFNG MBP TNF
43 chronic graft versus host disease 30.8 IFNG IL10 TNF TNFSF13B
44 rheumatic disease 30.7 APOH IFNG IL10 TNF
45 candidiasis 30.7 AIRE IFNG IL10 IL17A
46 bacterial infectious disease 30.6 IFNG IL10 IL17A TNF
47 inflammatory bowel disease 30.6 GAS5 IFNG IL10 IL17A STAT3 TNF
48 malaria 30.6 CTLA4 IFNG IL10 IL17A TNF
49 hypoadrenocorticism, familial 30.5 AIRE CTLA4 PTPN22
50 periodontitis 30.5 IFNG IL10 IL17A TNF
51 mycobacterium tuberculosis 1 30.5 IFNG IL10 IL17A TNF
52 human immunodeficiency virus infectious disease 30.5 IFNG IL10 TNF
53 polyradiculoneuropathy 30.5 IFNG IL10 IL17A MBP
54 endocarditis 30.5 APOH IL10 TNF
55 chlamydia 30.5 IFNG IL10 TNF
56 myeloma, multiple 30.4 GAS5 STAT3 TNF TNFSF13B
57 chagas disease 30.4 IFNG IL10 TNF
58 myelitis 30.3 APOH IL17A MBP TNF
59 intermediate uveitis 30.3 IFNG IL10 TNF
60 tropical spastic paraparesis 30.3 IFNG IL10 IL17A
61 spondyloarthropathy 30.3 IFNG IL10 IL17A TNF
62 q fever 30.3 IFNG IL10 TNF
63 gastrointestinal system disease 30.3 IFNG IL10 IL17A STAT3 TNF
64 brucellosis 30.3 IFNG IL10 TNF
65 leishmaniasis 30.3 IFNG IL10 TNF
66 osteomyelitis 30.2 IFNG IL10 TNF
67 toxoplasmosis 30.2 IFNG IL10 TNF
68 schistosomiasis 30.2 IFNG IL10 TNF
69 large granular lymphocyte leukemia 30.2 IFNG STAT3
70 autoimmune disease 1 12.6
71 autoimmune disease, multisystem, with facial dysmorphism 12.4
72 autoimmune disease, multisystem, infantile-onset, 1 12.4
73 autoimmune disease 6 12.4
74 vitiligo-associated multiple autoimmune disease susceptibility 6 12.3
75 autoimmune disease, multisystem, infantile-onset, 2 12.3
76 autoimmune disease of peripheral nervous system 12.2
77 autoimmune disease 2 12.1
78 autoimmune disease 3 12.1
79 autoimmune disease 4 12.1
80 autoimmune disease of gastrointestinal tract 12.0
81 autoimmune disease of skin and connective tissue 12.0
82 autoimmune disease of urogenital tract 12.0
83 autoimmune disease of blood 12.0
84 autoimmune disease of cardiovascular system 12.0
85 autoimmune disease of exocrine system 12.0
86 sjogren's syndrome, juvenile, secondary to autoimmune disease 12.0
87 itch e3 ubiquitin ligase deficiency 11.7
88 sjogren syndrome 11.4
89 celiac disease 1 11.3
90 undifferentiated connective tissue disease 11.3
91 stiff-person syndrome 11.3
92 igg4-related disease 11.3
93 pemphigus 11.3
94 primary biliary cholangitis 11.3
95 graves' disease 11.2
96 autoimmune hepatitis 11.2
97 premature ovarian failure 1 11.2
98 diabetes mellitus 11.2
99 pediatric autoimmune neuropsychiatric disorders associated with streptococcus infections 11.2
100 scleroderma, familial progressive 11.2
101 psoriasis 11.2
102 primary biliary cirrhosis 11.1
103 allergic encephalomyelitis 11.1
104 pemphigus vulgaris, familial 11.1
105 pemphigus vulgaris 11.1
106 dermatomyositis 11.1
107 celiac disease 6 11.1
108 juvenile rheumatoid arthritis 11.1
109 bullous pemphigoid 11.1
110 pemphigus foliaceus 11.1
111 fibromyalgia 11.1
112 myositis 11.1
113 systemic scleroderma 11.1
114 cogan syndrome 11.1
115 acquired hemophilia 11.1
116 rasmussen encephalitis 11.1
117 renal tubular acidosis, distal 11.1
118 anemia, autoimmune hemolytic 11.1
119 membranous nephropathy 11.1
120 autoimmune gastritis 11.1
121 pemphigus gestationis 11.1
122 aicardi-goutieres syndrome 11.1
123 optic neuritis 11.1
124 guillain-barre syndrome 11.1
125 polymyositis 11.1
126 immunoglobulin a deficiency 1 11.1
127 autoimmune polyendocrine syndrome, type i, with or without reversible metaphyseal dysplasia 11.1
128 c1q deficiency 11.1
129 hirata disease 11.1
130 cutaneous lupus erythematosus 11.1
131 lambert-eaton myasthenic syndrome 11.1
132 pure red-cell aplasia 11.1
133 capillary leak syndrome 11.1
134 cryoglobulinemia 11.1
135 evans' syndrome 11.1
136 acquired hemophilia a 11.1
137 cinca syndrome 11.1
138 mikulicz disease 11.1
139 jaccoud's syndrome 11.1
140 crest syndrome 11.1
141 autoimmune polyglandular syndrome type 3 11.0
142 insulin-resistance type b 11.0
143 aicardi-goutieres syndrome 1 11.0
144 sneddon syndrome 10.9
145 goodpasture syndrome 10.9
146 immunodeficiency 17 10.9
147 cold agglutinin disease 10.9
148 guillain-barre syndrome, familial 10.9
149 digeorge syndrome 10.9
150 purine nucleoside phosphorylase deficiency 10.9
151 familial cold autoinflammatory syndrome 3 10.9
152 immunodeficiency, common variable, 8, with autoimmunity 10.9
153 acquired von willebrand syndrome 10.9
154 alopecia areata 1 10.7
155 felty syndrome 10.7
156 yellow nail syndrome 10.7
157 bronchiectasis with or without elevated sweat chloride 1 10.7
158 buerger disease 10.7
159 complement component 2 deficiency 10.7
160 heart block, congenital 10.7
161 immune deficiency disease 10.7
162 pseudo-torch syndrome 1 10.7
163 chronic recurrent multifocal osteomyelitis 10.7
164 satoyoshi syndrome 10.7
165 microvascular complications of diabetes 1 10.7
166 birdshot chorioretinopathy 10.7
167 spondyloenchondrodysplasia with immune dysregulation 10.7
168 lipodystrophy, partial, acquired 10.7
169 granulomatosis with polyangiitis 10.7
170 bronchiectasis with or without elevated sweat chloride 2 10.7
171 bronchiectasis with or without elevated sweat chloride 3 10.7
172 reynolds syndrome 10.7
173 complement component 3 deficiency, autosomal recessive 10.7
174 masp2 deficiency 10.7
175 facial dysmorphism, immunodeficiency, livedo, and short stature 10.7
176 immunodeficiency 14 10.7
177 autoimmune interstitial lung, joint, and kidney disease 10.7
178 yao syndrome 10.7
179 immunodeficiency 52 10.7
180 autoimmune peripheral neuropathy 10.7
181 juvenile ankylosing spondylitis 10.7
182 autoimmune glomerulonephritis 10.7
183 autoimmune cardiomyopathy 10.7
184 autoimmune vasculitis 10.7
185 selective igm deficiency disease 10.7
186 exanthem 10.7
187 immunoglobulin beta deficiency 10.7
188 autoimmune neuropathy 10.7
189 cicatricial pemphigoid 10.7
190 palindromic rheumatism 10.7
191 miller fisher syndrome 10.7
192 autoimmune polyendocrine syndrome 10.7
193 adult-onset still's disease 10.7
194 gastric antral vascular ectasia 10.7
195 spinal cord disease 10.7
196 neuromuscular disease 10.7
197 acute disseminated encephalomyelitis 10.7
198 bullous skin disease 10.7
199 subcorneal pustular dermatosis 10.7
200 erythromelalgia 10.7
201 acquired angioedema 10.7
202 antisynthetase syndrome 10.7
203 autoimmune encephalitis 10.7
204 autoimmune gastrointestinal dysmotility 10.7
205 autoimmune oophoritis 10.7
206 collagenous gastritis 10.7
207 dysfibrinogenemia 10.7
208 enthesitis-related juvenile idiopathic arthritis 10.7
209 fibrillary glomerulonephritis 10.7
210 idiopathic hypertrophic pachymeningitis 10.7
211 immunotactoid glomerulopathy 10.7
212 immunotactoid or fibrillary glomerulopathy 10.7
213 microscopic polyangiitis 10.7
214 pseudopelade of brocq 10.7
215 psoriatic juvenile idiopathic arthritis 10.7
216 antiphospholipid syndrome, familial 10.7
217 velocardiofacial syndrome 10.7
218 megaloblastic anemia 1 10.7
219 surfactant metabolism dysfunction, pulmonary, 1 10.7
220 graves disease 1 10.7
221 autoimmune thyroid disease 3 10.7
222 immunoglobulin a deficiency 2 10.7
223 thiopurines, poor metabolism of, 1 10.7
224 lymphoproliferative syndrome 1 10.7
225 immunodeficiency 31c 10.7
226 complement component 4b deficiency 10.7
227 complement component 4a deficiency 10.7
228 drug-induced lupus erythematosus 10.7
229 gamma heavy chain disease 10.7
230 cryptosporidiosis 10.7
231 idiopathic cd4-positive t-lymphocytopenia 10.7
232 congenital myasthenic syndrome 10.7
233 acquired pure red cell aplasia 10.7
234 autoimmune autonomic ganglionopathy 10.7
235 autoimmune inner ear disease 10.7
236 eosinophilic granulomatosis with polyangiitis 10.7
237 paroxysmal cold hemoglobinuria 10.7
238 systemic onset juvenile idiopathic arthritis 10.7
239 hughes-stovin syndrome 10.7
240 contact dermatitis 10.7 IFNG IL10 TNF
241 paracoccidioidomycosis 10.7 CTLA4 IFNG IL10 TNF
242 clonorchiasis 10.7 IFNG IL10 TNF
243 chronic active epstein-barr virus infection 10.7 CTLA4 IFNG IL10
244 filariasis 10.7 CTLA4 IFNG IL10 TNF
245 lymphadenitis 10.7 IFNG IL10 STAT3 TNF
246 trichosporonosis 10.7 IFNG IL17A TNF
247 orofacial granulomatosis 10.7 IFNG IL10 TNF
248 poliomyelitis 10.7 IFNG IL10 TNF
249 eales disease 10.7 IFNG IL10 TNF
250 temporal arteritis 10.7 APOH IFNG PTPN22 TNF
251 spotted fever 10.7 IFNG IL10 TNF
252 omenn syndrome 10.7 AIRE IFNG IL10 TNF
253 coccidiosis 10.7 IFNG IL10 TNF
254 central nervous system vasculitis 10.7 IFNG IL17A TNF
255 aseptic meningitis 10.7 IFNG IL10 TNF
256 meningitis 10.7 IFNG IL10 TNF
257 primary systemic mycosis 10.7 IFNG IL10 IL17A TNF
258 mycoplasma pneumoniae pneumonia 10.7 IFNG IL10 IL17A TNF
259 plasmodium vivax malaria 10.7 IFNG IL10 TNF
260 leprosy 3 10.7 IFNG IL10 TNF
261 opportunistic mycosis 10.7 AIRE IFNG IL10 IL17A TNF
262 echinococcosis 10.7 IFNG IL10 IL17A TNF
263 acute graft versus host disease 10.7 IFNG IL10 TNF
264 bronchiolitis obliterans 10.7 IFNG IL10 IL17A TNF
265 bronchiolitis 10.7 IFNG IL10 IL17A TNF
266 lepromatous leprosy 10.7 IFNG IL10 TNF
267 allergic contact dermatitis 10.7 IFNG IL10 IL17A TNF
268 intestinal disease 10.7 IL10 IL17A STAT3 TNF
269 upper respiratory tract disease 10.7 IFNG IL10 IL17A TNF
270 bone inflammation disease 10.7 IFNG IL10 IL17A PTPN22 TNF
271 primary bacterial infectious disease 10.7 IFNG IL10 IL17A TNF
272 testicular disease 10.7 IFNG IL10 TNF
273 tropical endomyocardial fibrosis 10.7 IL10 TNF
274 proteasome-associated autoinflammatory syndrome 1 10.7 IFNG IL10 IL17A TNF
275 endomyocardial fibrosis 10.7 IL10 TNF
276 respiratory system disease 10.7 IFNG IL10 IL17A TNF
277 panuveitis 10.7 IL10 IL17A TNF
278 leptospirosis 10.7 IFNG IL10 TNF
279 hepatitis a 10.7 IFNG IL10 TNF
280 paranasal sinus disease 10.7 IFNG IL10 IL17A
281 extrinsic cardiomyopathy 10.7 IL10 IL17A TNF
282 dengue hemorrhagic fever 10.7 IFNG IL10 TNF
283 chronic mucocutaneous candidiasis 10.7 AIRE IFNG IL10 IL17A PTPN22 STAT3
284 parasitic protozoa infectious disease 10.7 IFNG IL10 TNF
285 viral encephalitis 10.7 IL10 MBP TNF TNFSF13B
286 cutaneous leishmaniasis 10.6 IFNG IL10 TNF
287 uveal disease 10.6 IL10 IL17A TNF
288 cephalosporin allergy 10.6 IFNG IL10
289 visceral leishmaniasis 10.6 IFNG IL10 TNF
290 aspergillosis 10.6 IFNG IL10 TNF
291 nervous system disease 10.6 IFNG IL10 MBP TNF
292 relapsing-remitting multiple sclerosis 10.6 IFNG IL10 IL17A MBP TNF
293 demyelinating disease 10.6 IFNG IL10 IL17A MBP TNF
294 toxic shock syndrome 10.6 IFNG IL10 TNF
295 primary progressive multiple sclerosis 10.6 IL10 MBP TNF
296 brain injury 10.6 ENO1 IL10 MBP
297 bronchial disease 10.6 IL10 IL17A TNF
298 transverse myelitis 10.6 APOH IL10 IL17A MBP TNF
299 central nervous system disease 10.6 IFNG IL17A MBP TNF
300 secondary progressive multiple sclerosis 10.6 IFNG IL10 MBP
301 plasmodium falciparum malaria 10.6 IFNG IL10 TNF
302 staphylococcal toxic shock syndrome 10.6 IFNG TNF
303 trypanosomiasis 10.6 IFNG IL10 TNF
304 acquired immunodeficiency syndrome 10.6 IFNG IL10 TNF
305 hyperlucent lung 10.6 IFNG IL10
306 palladium allergic contact dermatitis 10.6 IL10 IL17A
307 skin disease 10.6 IFNG IL10 IL17A TNF
308 mouth disease 10.6 IFNG IL10 TNF
309 pulmonary tuberculosis 10.6 IFNG IL10 TNF
310 multifocal choroiditis 10.6 IL10 TNF
311 type 1 diabetes mellitus 17 10.5 AIRE CTLA4
312 tungiasis 10.5 IL10 TNF
313 allergic asthma 10.5 IFNG IL10 IL17A
314 large intestine cancer 10.5 IFNG IL10 STAT3 TNF
315 sporotrichosis 10.5 IFNG IL10
316 nickel allergic contact dermatitis 10.5 IFNG IL10
317 transient hypogammaglobulinemia 10.4 IL10 TNF
318 lymphoma 10.3
319 neurosyphilis 10.3 IL10 IL17A
320 hepatitis 10.3
321 chronic beryllium disease 10.3 IFNG TNF
322 myasthenia gravis congenital 10.2
323 leukemia 10.2
324 hepatitis c 10.2
325 alopecia 10.2
326 thyroiditis 10.2
327 biliary cirrhosis, primary, 1 10.2
328 glomerulonephritis 10.1
329 schizophrenia 10.1
330 asthma 10.1
331 hepatitis c virus 10.1
332 thrombosis 10.1
333 autism 10.0
334 thymoma, familial 10.0
335 thymoma 10.0
336 osteoporosis 10.0
337 thrombocytopenia 10.0
338 antiphospholipid syndrome 10.0
339 pneumonia 10.0
340 neuromyelitis optica spectrum disorder 10.0
341 dermatitis 10.0
342 pancreatitis 10.0
343 myocarditis 10.0
344 cholangitis 10.0
345 breast cancer 10.0
346 cholangitis, primary sclerosing 10.0
347 sclerosing cholangitis 10.0
348 endometriosis 10.0
349 depression 10.0
350 leukemia, chronic lymphocytic 2 9.9
351 lymphoma, mucosa-associated lymphoid type 9.9
352 leukemia, chronic lymphocytic 9.9
353 aging 9.9
354 myelodysplastic syndrome 9.9
355 immunoglobulin alpha deficiency 9.9
356 lymphocytic leukemia 9.9
357 melanoma 9.9
358 leukemia, b-cell, chronic 9.9
359 lymphoma, hodgkin, classic 9.9
360 spondylocarpotarsal synostosis syndrome 9.9
361 pertussis 9.9
362 hypothyroidism 9.9
363 purpura 9.9
364 gastritis 9.9
365 lymphopenia 9.9
366 spondylitis 9.9
367 myeloid leukemia 9.9
368 choreatic disease 9.9
369 spondyloarthropathy 1 9.9
370 pulmonary hypertension, primary, 1 9.9
371 leukemia, acute myeloid 9.9
372 lymphoma, non-hodgkin, familial 9.9
373 aplastic anemia 9.9
374 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.9
375 hyperprolactinemia 9.9
376 autoimmune lymphoproliferative syndrome, type v 9.9
377 pulmonary hypertension 9.9
378 neutropenia 9.9
379 enthesopathy 9.9
380 hyperthyroidism 9.9
381 herpes zoster 9.9
382 neuropathy 9.9
383 narcolepsy 9.9
384 lichen sclerosus 9.9
385 lymphomatous thyroiditis 9.9
386 amyotrophic lateral sclerosis 1 9.8
387 attention deficit-hyperactivity disorder 9.8
388 ige responsiveness, atopic 9.8
389 obsessive-compulsive disorder 9.8
390 sarcoidosis 1 9.8
391 lung cancer 9.8
392 moyamoya disease 1 9.8
393 rheumatic fever-related antigen 9.8
394 helicobacter pylori infection 9.8
395 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.8
396 hepatitis b 9.8
397 liver disease 9.8
398 pol iii-related leukodystrophies 9.8
399 renal tubular acidosis 9.8
400 silicosis 9.8
401 sleep apnea 9.8
402 glucocorticoid-induced osteoporosis 9.8
403 heart disease 9.8
404 pulmonary alveolar proteinosis 9.8
405 urticaria 9.8
406 rheumatic fever 9.8
407 epilepsy 9.8
408 lateral sclerosis 9.8
409 relapsing polychondritis 9.8
410 turner syndrome 9.8
411 aortic aneurysm 9.8
412 infertility 9.8
413 amyloidosis 9.8
414 encephalitis 9.8
415 irritable bowel syndrome 9.8
416 lymphomatoid papulosis 9.8
417 macrophage activation syndrome 9.8
418 encephalopathy 9.8
419 down syndrome 9.8
420 diabetes mellitus, noninsulin-dependent 9.8
421 pernicious anemia 9.8
422 chondrodysplasia punctata syndrome 9.8
423 psoriatic arthritis 9.8
424 bipolar disorder 9.8
425 crohn's disease 9.8
426 diffuse large b-cell lymphoma 9.8
427 dilated cardiomyopathy 9.8
428 liver cirrhosis 9.8
429 cutaneous t cell lymphoma 9.8
430 lymphoproliferative syndrome 9.8
431 nodal marginal zone lymphoma 9.8
432 hypogonadotropic hypogonadism 9.8
433 hypoparathyroidism 9.8
434 dementia 9.8
435 squamous cell papilloma 9.8
436 interstitial cystitis 9.8
437 cholera 9.8
438 thrombocytopenia due to platelet alloimmunization 9.8
439 cystitis 9.8
440 thyroid cancer 9.8
441 papilloma 9.8
442 iga glomerulonephritis 9.8
443 pustulosis of palm and sole 9.8
444 influenza 9.8
445 lung disease 9.8
446 chickenpox 9.8
447 eating disorder 9.8
448 lichen planus 9.8
449 heparin-induced thrombocytopenia 9.8
450 hypoxia 9.8
451 cytomegalovirus infection 9.8
452 kabuki syndrome 1 9.7
453 sydenham chorea 9.7
454 persian gulf syndrome 9.7
455 spastic paraparesis 9.7
456 thrombotic thrombocytopenic purpura, acquired 9.7
457 neonatal lupus erythematosus 9.7
458 alzheimer disease 9.7
459 atherosclerosis susceptibility 9.7
460 blood group, colton system 9.7
461 meniere disease 9.7
462 parkinson disease, late-onset 9.7
463 thrombocytopenic purpura, autoimmune 9.7
464 thrombophilia due to thrombin defect 9.7
465 alopecia universalis congenita 9.7
466 eosinophilic fasciitis 9.7
467 familial mediterranean fever 9.7
468 dermatitis herpetiformis, familial 9.7
469 horns in sheep 9.7
470 cervical cancer 9.7
471 anxiety 9.7
472 gastric cancer 9.7
473 mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome 9.7
474 deficiency anemia 9.7
475 acute leukemia 9.7
476 childhood type dermatomyositis 9.7
477 chronic granulomatous disease 9.7
478 chronic inflammatory demyelinating polyneuropathy 9.7
479 hemolytic anemia 9.7
480 hydrocephalus 9.7
481 osteonecrosis 9.7
482 polycystic ovary syndrome 9.7
483 autoimmune polyendocrine syndrome type 1 9.7
484 janus kinase-3 deficiency 9.7
485 collagenous colitis 9.7
486 penicillin allergy 9.7
487 sensorineural hearing loss 9.7
488 mastitis 9.7
489 portal hypertension 9.7
490 premature menopause 9.7
491 goiter 9.7
492 scleritis 9.7
493 biliary atresia 9.7
494 pemphigoid gestationis 9.7
495 prostatitis 9.7
496 pericarditis 9.7
497 hypogonadism 9.7
498 dyspepsia 9.7
499 thrombophilia 9.7
500 orchitis 9.7
501 agammaglobulinemia 9.7
502 epidermolysis bullosa 9.7
503 nonspecific interstitial pneumonia 9.7
504 membranoproliferative glomerulonephritis 9.7
505 vaccinia 9.7
506 mood disorder 9.7
507 epidermolysis bullosa acquisita 9.7
508 movement disease 9.7
509 progressive multifocal leukoencephalopathy 9.7
510 adenoma 9.7
511 monoclonal gammopathy of uncertain significance 9.7
512 hypogonadotropism 9.7
513 peptic ulcer disease 9.7
514 localized scleroderma 9.7
515 dermatitis herpetiformis 9.7
516 collagen disease 9.7
517 rubella 9.7
518 atrophic gastritis 9.7
519 macroglobulinemia 9.7
520 hypopituitarism 9.7
521 postpartum depression 9.7
522 fasciitis 9.7
523 hypoglycemia 9.7
524 al amyloidosis 9.7
525 autoimmune atrophic gastritis 9.7
526 banti's syndrome 9.7
527 bowenoid papulosis 9.7
528 congenital hydrocephalus 9.7
529 cytokine deficiency 9.7
530 giant cell myocarditis 9.7
531 oral lichen planus 9.7
532 pediatric ulcerative colitis 9.7
533 dysautonomia 9.7
534 granulomatous mastitis 9.7
535 paraneoplastic pemphigus 9.7
536 diffuse alveolar hemorrhage 9.7
537 acanthosis nigricans 9.6
538 cardiac conduction defect 9.6
539 melkersson-rosenthal syndrome 9.6
540 myelopathy, htlv-1-associated 9.6
541 small cell cancer of the lung 9.6
542 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 9.6
543 lambert syndrome 9.6
544 interstitial pneumonitis, desquamative, familial 9.6
545 sudden infant death syndrome 9.6
546 ataxia and polyneuropathy, adult-onset 9.6
547 ovarian hyperstimulation syndrome 9.6
548 leukemia, acute lymphoblastic 9.6
549 acute lymphocytic leukemia 9.6
550 glycogen storage disease 9.6
551 keratoconus 9.6
552 marginal zone b-cell lymphoma 9.6
553 splenic marginal zone lymphoma 9.6
554 desquamative interstitial pneumonia 9.6
555 t cell deficiency 9.6
556 tetanus 9.6
557 porphyria 9.6
558 glossopharyngeal neuralgia 9.6
559 panniculitis 9.6
560 squamous cell carcinoma 9.6
561 acromegaly 9.6
562 kidney cancer 9.6
563 milk allergy 9.6
564 dyslexia 9.6
565 anca-associated vasculitis 9.6
566 autoimmune enteropathy 9.6
567 broken heart syndrome 9.6
568 glossodynia 9.6
569 homologous wasting disease 9.6
570 htlv-1 associated myelopathy/tropical spastic paraparesis 9.6
571 human t-cell leukemia virus type 1 9.6
572 opsoclonus-myoclonus syndrome 9.6
573 secondary adrenal insufficiency 9.6
574 t-cell/histiocyte rich large b cell lymphoma 9.6
575 myoclonus 9.6
576 seizure disorder 9.6
577 secondary erythromelalgia 9.6
578 adenohypophysitis 9.6
579 cytophagic histiocytic panniculitis 9.6
580 aortic aneurysm, familial abdominal, 1 9.5
581 atrial standstill 1 9.5
582 aortic valve disease 1 9.5
583 colorectal cancer 9.5
584 creutzfeldt-jakob disease 9.5
585 cryoglobulinemia, familial mixed 9.5
586 factor viii deficiency 9.5
587 gilles de la tourette syndrome 9.5
588 hypertension, essential 9.5
589 hypertriglyceridemia, familial 9.5
590 inclusion body myositis 9.5
591 kaposi sarcoma 9.5
592 keratitis, hereditary 9.5
593 lichen sclerosus et atrophicus 9.5
594 migraine with or without aura 1 9.5
595 carney complex, type 1 9.5
596 neurofibromatosis, type i 9.5
597 neurofibromatosis, type iv, of riccardi 9.5
598 noonan syndrome 1 9.5
599 ocular cicatricial pemphigoid 9.5
600 prostate cancer 9.5
601 raynaud disease 9.5
602 keratosis, seborrheic 9.5
603 telangiectasia, hereditary benign 9.5
604 triiodothyronine receptor auxiliary protein 9.5
605 williams-beuren syndrome 9.5
606 achalasia, familial esophageal 9.5
607 chondrosarcoma 9.5
608 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.5
609 wolfram syndrome 1 9.5
610 neuropathy, hereditary sensory and autonomic, type iii 9.5
611 hypogonadism, male 9.5
612 3-methylglutaconic aciduria, type iii 9.5
613 pancreatic cancer 9.5
614 polycythemia vera 9.5
615 autoimmune polyendocrine syndrome, type ii 9.5
616 insulin-like growth factor i 9.5
617 fragile x syndrome 9.5
618 hemophilia a 9.5
619 rett syndrome 9.5
620 frontotemporal dementia 9.5
621 pituitary adenoma, prolactin-secreting 9.5
622 deafness, autosomal dominant 6 9.5
623 acute insulin response 9.5
624 autoimmune lymphoproliferative syndrome 9.5
625 prostate cancer, hereditary, 8 9.5
626 homocysteinemia 9.5
627 sickle cell anemia 9.5
628 caronte 9.5
629 aceruloplasminemia 9.5
630 immunodeficiency with hyper-igm, type 2 9.5
631 body mass index quantitative trait locus 1 9.5
632 neutrophilic dermatosis, acute febrile 9.5
633 myocardial infarction 9.5
634 severe cutaneous adverse reaction 9.5
635 ichthyosis prematurity syndrome 9.5
636 human immunodeficiency virus type 1 9.5
637 prostate cancer, hereditary, 6 9.5
638 celiac disease 3 9.5
639 noonan syndrome 3 9.5
640 bone mineral density quantitative trait locus 8 9.5
641 lipoprotein glomerulopathy 9.5
642 diabetes mellitus, ketosis-prone 9.5
643 systemic lupus erythematosus 11 9.5
644 acute promyelocytic leukemia 9.5
645 microvascular complications of diabetes 5 9.5
646 bone mineral density quantitative trait locus 15 9.5
647 complement component c1s deficiency 9.5
648 beta-thalassemia 9.5
649 peripartum cardiomyopathy 9.5
650 human herpesvirus 8 9.5
651 infantile liver failure syndrome 1 9.5
652 nevus comedonicus 9.5
653 acute kidney failure 9.5
654 acute liver failure 9.5
655 alcoholic liver cirrhosis 9.5
656 breast reconstruction 9.5
657 cataract 9.5
658 chronic myelomonocytic leukemia 9.5
659 ectodermal dysplasia 9.5
660 heart valve disease 9.5
661 hemophagocytic lymphohistiocytosis 9.5
662 ischemic heart disease 9.5
663 joint disorders 9.5
664 keloids 9.5
665 lymphoid leukemia 9.5
666 multifocal motor neuropathy 9.5
667 osteoarthritis 9.5
668 pulmonary fibrosis 9.5
669 spinal cord injury 9.5
670 thalassemia 9.5
671 chlamydia pneumonia 9.5
672 erythema multiforme 9.5
673 vitamin b12 deficiency 9.5
674 rheumatic heart disease 9.5
675 interleukin-7 receptor alpha deficiency 9.5
676 b cell linker protein deficiency 9.5
677 autism spectrum disorder 9.5
678 alexithymia 9.5
679 atrial fibrillation 9.5
680 castleman disease 9.5
681 xerophthalmia 9.5
682 sialadenitis 9.5
683 asbestosis 9.5
684 pre-eclampsia 9.5
685 protein-losing enteropathy 9.5
686 interstitial nephritis 9.5
687 thrombotic thrombocytopenic purpura 9.5
688 sarcoma 9.5
689 respiratory failure 9.5
690 primary hyperparathyroidism 9.5
691 hemopericardium 9.5
692 autonomic neuropathy 9.5
693 pericardial effusion 9.5
694 nephrotic syndrome 9.5
695 conn's syndrome 9.5
696 sympathetic ophthalmia 9.5
697 otosclerosis 9.5
698 patulous eustachian tube 9.5
699 hemolytic-uremic syndrome 9.5
700 posterior uveitis 9.5
701 leiomyoma 9.5
702 telangiectasis 9.5
703 keratoconjunctivitis sicca 9.5
704 paronychia 9.5
705 crescentic glomerulonephritis 9.5
706 acute cystitis 9.5
707 megaesophagus 9.5
708 gout 9.5
709 endemic goiter 9.5
710 hyperparathyroidism 9.5
711 eclampsia 9.5
712 polyneuropathy 9.5
713 blackwater fever 9.5
714 hereditary angioedema 9.5
715 disease of mental health 9.5
716 angioedema 9.5
717 keratosis 9.5
718 vascular disease 9.5
719 calcinosis 9.5
720 hyperostosis 9.5
721 nocardiosis 9.5
722 psychotic disorder 9.5
723 sensory peripheral neuropathy 9.5
724 myoma 9.5
725 hairy cell leukemia 9.5
726 severe acute respiratory syndrome 9.5
727 adenocarcinoma 9.5
728 food allergy 9.5
729 complex regional pain syndrome 9.5
730 ischemia 9.5
731 thymic carcinoma 9.5
732 periodontal disease 9.5
733 skin carcinoma 9.5
734 breast adenocarcinoma 9.5
735 cellulitis 9.5
736 plasmacytoma 9.5
737 arthropathy 9.5
738 intestinal pseudo-obstruction 9.5
739 merkel cell carcinoma 9.5
740 hyperglycemia 9.5
741 pyoderma 9.5
742 myopathy 9.5
743 coronary restenosis 9.5
744 conjunctivochalasis 9.5
745 peanut allergy 9.5
746 calciphylaxis 9.5
747 anti-basement membrane glomerulonephritis 9.5
748 spindle cell hemangioma 9.5
749 chronic inflammatory demyelinating polyradiculoneuropathy 9.5
750 demyelinating polyneuropathy 9.5
751 von economo's disease 9.5
752 blepharospasm 9.5
753 dystonia 9.5
754 kidney disease 9.5
755 lymphoepithelioma-like carcinoma 9.5
756 peripheral nervous system disease 9.5
757 complement deficiency 9.5
758 peritonitis 9.5
759 scabies 9.5
760 polycythemia 9.5
761 mucormycosis 9.5
762 chronic fatigue syndrome 9.5
763 pyoderma gangrenosum 9.5
764 herpes simplex 9.5
765 parasitic helminthiasis infectious disease 9.5
766 rosacea 9.5
767 skin melanoma 9.5
768 learning disability 9.5
769 autosomal dominant polycystic kidney disease 9.5
770 achalasia 9.5
771 keratoconjunctivitis 9.5
772 diabetes insipidus 9.5
773 blepharitis 9.5
774 pulmonary embolism 9.5
775 yellow fever 9.5
776 polyarteritis nodosa 9.5
777 hypereosinophilic syndrome 9.5
778 hemophilia 9.5
779 myotonic dystrophy 9.5
780 polycystic kidney disease 9.5
781 c3 glomerulopathy 9.5
782 wfs1-related disorders 9.5
783 acute zonal occult outer retinopathy 9.5
784 amyloidosis aa 9.5
785 anti-pit-1 antibody syndrome 9.5
786 chromosome xp deletion 9.5
787 chronic intestinal pseudoobstruction 9.5
788 diabetic mastopathy 9.5
789 gigantomastia 9.5
790 haemophilus influenzae 9.5
791 idiopathic achalasia 9.5
792 idiopathic inflammatory myopathy 9.5
793 lrba deficiency 9.5
794 lymphocytic hypophysitis 9.5
795 myotonia atrophica 9.5
796 neisseria meningitidis infection 9.5
797 nodular regenerative hyperplasia 9.5
798 pdgfrb-associated chronic eosinophilic leukemia 9.5
799 pediatric multiple sclerosis 9.5
800 pleuroparenchymal fibroelastosis 9.5
801 pseudo-turner syndrome 9.5
802 sudden sensorineural hearing loss 9.5
803 systemic capillary leak syndrome 9.5
804 dysphagia 9.5
805 headache 9.5
806 idiopathic bilateral vestibulopathy 9.5
807 asbestos intoxication 9.5
808 igg4-related mesenteritis 9.5
809 recurrent acute pancreatitis 9.5
810 methotrexate-associated lymphoproliferative disorders 9.5
811 pemphigus vegetans 9.5
812 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.5

Graphical network of the top 20 diseases related to Autoimmune Disease:



Diseases related to Autoimmune Disease

Symptoms & Phenotypes for Autoimmune Disease

Human phenotypes related to Autoimmune Disease:

33 (showing 1, show less)
# Description HPO Frequency HPO Source Accession
1 autoimmune antibody positivity 33 HP:0030057

Symptoms via clinical synopsis from OMIM:

58
Immunology:
autoimmune disease

Lab:
high titer autoantibody

Clinical features from OMIM:

109100

MGI Mouse Phenotypes related to Autoimmune Disease:

47 (showing 6, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.13 AIRE CTLA4 IFNG IL10 IL17A ITCH
2 homeostasis/metabolism MP:0005376 10.03 AIRE APOH CTLA4 IFNG IL10 IL17A
3 digestive/alimentary MP:0005381 9.97 AIRE CTLA4 IFNG IL10 IL17A PTPN22
4 immune system MP:0005387 9.97 AIRE CTLA4 IFNG IL10 IL17A ITCH
5 liver/biliary system MP:0005370 9.5 AIRE CTLA4 IFNG IL10 PTPN22 STAT3
6 respiratory system MP:0005388 9.28 AIRE CTLA4 IFNG IL10 IL17A ITCH

Drugs & Therapeutics for Autoimmune Disease

Drugs for Autoimmune Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 1256, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sofosbuvir Approved Phase 4 1190307-88-0 45375808
2
Ledipasvir Approved Phase 4 1256388-51-8 67505836
3
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 79902-63-9 54454
4
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 53-03-2 5865
5
Azithromycin Approved Phase 4,Phase 2,Phase 1 83905-01-5 447043 55185
6
Selenium Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 7782-49-2
7
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 7440-66-6 32051
8
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
9
tannic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1401-55-4
10
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 24280-93-1 446541
11
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1994-09-7, 94-09-7 2337
12
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 302-25-0
13
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
14
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2921-57-5
15
Insulin Aspart Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 116094-23-6 16132418
16
Insulin Lispro Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 133107-64-9
17
Insulin glulisine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 207748-29-6
18
Enalapril Approved, Vet_approved Phase 4,Phase 2,Not Applicable 75847-73-3 40466924 5362032
19
Enalaprilat Approved Phase 4,Phase 2,Not Applicable 76420-72-9 6917719
20
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 174722-31-7 10201696
21
Saxagliptin Approved Phase 4,Phase 3,Phase 2 361442-04-8 11243969
22
Pancrelipase Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 53608-75-6
23
Glucagon Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 16941-32-5
24
Losartan Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 114798-26-4 3961
25
Angiotensin II Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 11128-99-7, 68521-88-0, 4474-91-3 172198
26
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 331731-18-1 16219006
27
gastric inhibitory polypeptide Approved, Investigational Phase 4,Not Applicable 100040-31-1
28
Insulin Detemir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 169148-63-4 5311023
29
Insulin glargine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 160337-95-1
30
Glyburide Approved Phase 4,Phase 2,Phase 3,Not Applicable 10238-21-8 3488
31
Hydrocortisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-23-7 5754
32
Hydrocortisone acetate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-03-3
33
Natalizumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 189261-10-7
34
4-Aminopyridine Approved Phase 4,Phase 3,Phase 2,Not Applicable 504-24-5 1727
35
Mitoxantrone Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 65271-80-9 4212
36
Interferon beta-1b Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 145155-23-3
37
Exenatide Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 141758-74-9 15991534
38
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-05-9 143 6006
39
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 1959-05-2, 59-05-2 126941
40
Abatacept Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 332348-12-6 10237
41
Sulfasalazine Approved Phase 4,Phase 3,Phase 2,Not Applicable 599-79-1 5359476 5353980
42
Hydroxychloroquine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 118-42-3 3652
43
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 185243-69-0
44
Leflunomide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 75706-12-6 3899
45
Infliximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 170277-31-3
46
Certolizumab pegol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 428863-50-7
47
Diazoxide Approved Phase 4 364-98-7 3019
48
Etoricoxib Approved, Investigational Phase 4,Phase 3,Phase 2 202409-33-4 123619
49
Diclofenac Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 15307-86-5 3033
50
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 64-17-5 702
51
Naltrexone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 16590-41-3 5360515
52
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 1177-87-3
53
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 50-02-2 5743
54
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-18-0, 6055-19-2 2907
55
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 22916-47-8 4189
56
Calcium Carbonate Approved, Investigational Phase 4,Phase 3,Phase 2 471-34-1
57
alemtuzumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 216503-57-0
58
Propylthiouracil Approved, Investigational Phase 4,Phase 3,Phase 2 51-52-5 657298